Skip to content

FFA Metabolism in Different Types of Human Obesity

FFA Metabolism in Different Types of Human Obesity

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00068900
Enrollment
0
Registered
2003-09-12
Start date
2003-11-30
Completion date
2004-02-29
Last updated
2015-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

We will give intravenous fat molecules to help us understand how the fat that is released from peoples fat cells is used. This will be done when people are eating, not eating and walking.

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

BMI 28-36 -upper body obesity and lower body obesity non-obese BMI 19-24. Females premenopausal. Must be a non-smoker.

Exclusion criteria

BP\> 160/95 on HTN meds, known systemic illness. Medications that affect fat metabolism. We do no cover travel expenses. Known heart and vascular disease.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026